Schrodinger Stock Forecast
NASDAQ: SDGRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
SDGR analyst consensus
Consensus (7 analysts)
none
Avg. price target
$21.43-21.47%
- Strong buy 0
- Buy 5
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering Schrodinger (2026-10-07), 5 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $21.43, with a high estimate of $30.00 and a low estimate of $17.00. The average target implies downside of 21.5% from the current price of $27.29.
The spread between the highest and lowest targets is 76.5%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for SDGR.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 5 | 71% |
| Hold | 2 | 29% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $17.00 | -37.71% |
| Average target | $21.43 | -21.47% |
| High target | $30.00 | +9.93% |